The study enrolled 126 people with untreated Parkinson's disease, a progressive neurological disorder that impairs the brain's nerve cells and affects the production of dopamine, a neurotransmitter that regulates functions such as memory, movement and mood. Read more: https://pharma.economictimes.indiatimes.com/news/research-and-development/inhibikase-therapeutics-stops-parkinsons-drug-development-as-it-fails-to-show-benefits-in-study/117713877